Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Upstate Biotechnology
Lake Placid, New York, United Statesupstate.com ↗
- Ownership
- Private
- Employees
- ~260
- Development stage
- Other
01
Overview
Upstate Biotechnology was a leading developer of cell signaling reagents (antibodies, kinases, GPRCs, inhibitors, growth products), enabling high-throughput screening and target validation. Their kinase portfolio was among the largest in the industry and their reagents were widely used in preclinical discovery.
- Therapeutic areas
- Other
- Modalities
- AntibodySmall moleculeProtein
- Industry
- Non-Drug Biotech
02
Partnerships
Numerous pharmaceutical and biotech service partnerships (contract kinase screening for pharma/biotech companies)
Beyond the preview
Go deeper on Upstate Biotechnology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Upstate Biotechnology.